Sign up for email alerts of latest news, events, new funding opportunities and more.
Showing all Industry Success Stories
9 Nov 2017
In 2016, an app developed by scientists at the University of Manchester Farr Institute Of Health Informatics Research became a finalist at the annual AXA PPP Health Tech & You Awards. ClinTouch is a pioneering mobile phone app designed to improve the care and lives of people living with psychosis by monitoring real-time symptoms and reducing unscheduled and emergency hospital admissions.
9 Nov 2017
In 2016, Bicycle Therapeutics - a MRC spin out company - entered into a collaboration with AstraZeneca potentially worth $1bn. The collaboration will identify and develop novel peptides --compounds consisting of two or more amino acids linked in a chain -- to treat respiratory, cardiovascular and metabolic diseases.
7 Nov 2017
MRC-funded scientists at the University of Sheffield have identified a new treatment approach for patients with a rare inherited immune disorder known as Activated PI3-kinase Delta Syndrome (APDS) which causes increased susceptibility to infection.
7 Nov 2017
In January 2015, scientists at the MRC London Institute of Medical Sciences (LMS) published the results of a meticulous ‘proof of concept’ study looking for a mechanism underlying inherited heart disease.
1 Nov 2017
MRC-funded scientists at the UCL Institute of Child Health have developed a successful treatment for children with ‘Bubble boy disease’, a rare immune disorder. In 2015, this work led to the launch of Orchard Therapeutics, a spin-out company which aims to further develop gene therapy to benefit patients with serious and life-threatening diseases.
21 Aug 2017
In 2015, the newly formed MRC Immunopsychiatry Consortium worked closely with pharmaceutical company Janssen to launch a new Phase II clinical trial. This trial will investigate whether the anti-inflammatory drug sirukumab could be used to treat depression using insights from the Consortium that suggest a link between inflammation and depression.
16 Aug 2017
A new molecule identified in 2015 by MRC-funded research has been patented and licensed by a start-up pharmaceutical company in France. Experiments in mice have shown that this molecule, called Sephin1, is able to prevent the formation of protein tangles that are a hallmark of neurodegenerative diseases
2 Aug 2017
Academic groups working in discovery science will have two new opportunities to access state-of-the-art industry facilities from today.
20 Jun 2017
A promising clinical trial testing an HIV vaccine is due to be completed in 2018. The RIVER clinical trial is the culmination of decades of painstaking work by MRC-funded researchers towards developing a vaccine to prevent and cure HIV infections.
14 Mar 2017
A change to the MRC industrial Collaborative Awards in Science and Engineering (CASE) studentships scheme will see studentships allocated directly to research organisations for two intake years.